drugset / Trial / NCT02306837

Consolidation Chemotherapy After Autologous Stem Cell Transplantation for Lymphoid Malignancies

NCT02306837 ↗

NaSingle-groupOpen-labelTreatment

Summary

To imporve the outcome of patients with relapsed/refractory lymphoma, we conduct a clinical trial to test the efficacy and feasibility of consolidation chemotherapy after autologous stem cell transplantation

Timeline

Start
2014-09
Primary completion
2018-09
Completion
2019-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bu-CY-E Unknown — —